Treatment ends. The appointments stop. The clinical team that organized your life for months disperses, and you’re left with the question almost no one prepares you for: now what?
That question defines survivorship. For too many patients the answer is silence: a completed chart, a follow-up schedule, and a return to daily life with a body that’s been through something significant and a system that has largely moved on.
The research confirms what patients already know. A systematic review published in the British Journal of Cancer in 2025 examined ten clinical practice guidelines for long-term breast cancer survivorship and concluded they inadequately cover survivors’ needs, with persistent gaps in psychosocial support, lifestyle guidance, and management of late effects. A national survey of medical oncologists published in the Journal of Cancer Survivorship in 2022 found that 78% reported routinely evaluating patients for disease recurrence, while only 34% assessed psychosocial long-term and late effects. Surviving is not the same as being supported through survival.
The information environment that fills the gap.
When clinical guidance is absent, patients go looking for answers on their own, and what they find online is a specific kind of fear: parabens cause cancer, aluminum causes cancer, fragrance causes cancer, everything in your bathroom cabinet is a threat. The wellness market has recognized survivorship as an audience and responded with products and messaging calibrated to anxiety rather than evidence.
Patients end up trading clinical silence for commercial noise. Neither serves them well.
The standard I apply to any recommendation for a patient navigating a hormone-sensitive cancer is the same standard I applied when formulating InviCible Skincare™: what does the evidence actually support, and what doesn’t it?
What the evidence says about skincare after cancer treatment.
Radiation changes skin structure, reducing elasticity and increasing sensitivity. Chemotherapy affects the skin barrier, often causing dryness, fragility, and increased reactivity. Hormonal therapies alter sebum production and collagen density. The skin that emerges from treatment isn’t the same skin that entered it.
The clinical literature supports a few principles consistently, and honesty about what the evidence shows matters as much as the principles themselves.
Fragrance is the clearest case, and the reason has nothing to do with cancer. Skin often becomes dry, sensitive, or irritated during and after chemotherapy and radiation, and fragrance is one of the most common irritants and causes of contact sensitization in reactive skin. Fragrance-free, hypoallergenic products are a practical choice on tolerance grounds alone.
Parabens and phthalates deserve a more careful answer than the internet gives. They can weakly mimic estrogen in laboratory studies, which is why they raise concern, particularly for people with hormone receptor-positive breast cancer. The human evidence connecting everyday cosmetic exposure to breast cancer risk or recurrence is limited and inconclusive, and no major guideline body, including NCCN or ASCO, currently recommends that survivors avoid these ingredients. Avoiding them is a reasonable precautionary choice some patients make for peace of mind. The evidence doesn’t require it, and any marketing that tells you otherwise is selling fear.
Prioritize barrier repair: ingredients like vitamin C, niacinamide, and hyaluronic acid are well supported for skin barrier function and safe for this population.
A note on vitamin C specifically, because there’s confusion worth clearing up. The concerns about vitamin C in oncology relate to high-dose oral or intravenous supplementation and its potential to interfere with certain chemotherapy agents. Topical vitamin C is categorically different, with an excellent safety profile and strong data for antioxidant protection, collagen synthesis support, and skin barrier repair.
One practical thing every patient should know: vitamin C loses its potency entirely when it oxidizes, and oxidized vitamin C is brown. If a vitamin C product is brown when you open it, the active ingredient is already gone. Tinted formulations and opaque packaging can make this hard to check, so look before you buy and look again before you use.
Why InviCible exists.
It started as something more specific than a skincare brand. After reconstruction, my patients needed a safe, evidence-based scar care option. I formulated it fragrance-free for skin tolerance, and left out parabens and phthalates as a deliberate precaution for patients navigating hormone-sensitive cancers, the same peace-of-mind choice many of those patients were already making for themselves. Patients kept using it long after their scars had faded, eventually as a daily primer. The market found the product before I went looking for a market.
That origin still sets the standard. It was formulated for the most medically demanding use case and adopted broadly because it worked.
The larger gap.
Skincare is one dimension of survivorship. It’s addressable, which is why it’s worth addressing directly. The “now what” question is bigger, though: it touches identity, body image, intimacy, fear of recurrence, the loss of the structure treatment provided, and the absence of a clinical team that was present for every hard moment. (I’ve written about how informed decision-making should work before surgery; the same principle applies after treatment ends.)
Survivorship is not an afterthought. It is a phase of care, and it deserves the same rigor and the same commitment to patient-centered design we apply to everything that comes before it.
The standard you received during treatment is the standard you deserve after it.
Related reading: What to Ask Before Saying Yes to Breast Reconstruction →